Impact of IL-1 inhibition on fatigue associated with autoinflammatory syndromes

P02-027 - Quality of life in CAPS treated by Canakinumab

(2013) C Marsaud et al.   Pediatric Rheumatology

Canakinumab in patients with cryopyrin-associated periodic syndrome: an update for clinicians

(2013) Jasmin B. Kuemmerle-Deschner et al.   Therapeutic Advances in Musculoskeletal Disease

Sustained response and prevention of damage progression in patients with neonatal-onset multisystem inflammatory disease treated with anakinra: A cohort study to determine three- and five-year outcomes

(2012) Cailin H. Sibley et al.   ARTHRITIS AND RHEUMATISM

The Use of Canakinumab, a Novel IL-1β Long-Acting Inhibitor, in Refractory Adult-Onset Still's Disease

(2012) Apostolos Kontzias et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Etiopatogenia de los síndromes asociados a criopirina: genética, bases moleculares y el inflamasoma

(2011) Juan I. Aróstegui   MEDICINA CLINICA

Biological mechanisms of chronic fatigue

(2011) K. B. Norheim et al.   RHEUMATOLOGY

Measures of fatigue: Bristol Rheumatoid Arthritis Fatigue Multi-Dimensional Questionnaire (BRAF MDQ), Bristol Rheumatoid Arthritis Fatigue Numerical Rating Scales (BRAF NRS) for Severity, Effect, and Coping, Chalder Fatigue Questionnaire (CFQ), Checklist

(2011) Sarah Hewlett et al.   ARTHRITIS CARE & RESEARCH

NLRP3 E311K mutation in a large family with Muckle-Wells syndrome - description of a heterogeneous phenotype and response to treatment

(2011) Jasmin B Kuemmerle-Deschner et al.   ARTHRITIS RESEARCH & THERAPY

Canakinumab (ACZ885, a fully human IgG1 anti-IL-1β mAb) induces sustained remission in pediatric patients with cryopyrin-associated periodic syndrome (CAPS)

(2011) Jasmin B Kuemmerle-Deschner et al.   ARTHRITIS RESEARCH & THERAPY

Sustained remission of symptoms and improved health-related quality of life in patients with cryopyrin-associated periodic syndrome treated with canakinumab: results of a double-blind placebo-controlled randomized withdrawal study

(2011) Isabelle Koné-Paut et al.   ARTHRITIS RESEARCH & THERAPY

Current Status of Understanding the Pathogenesis and Management of Patients With NOMID/CINCA

(2011) Raphaela Goldbach-Mansky   Current Rheumatology Reports

Mutations in the autoinflammatory cryopyrin-associated periodic syndrome gene: epidemiological study and lessons from eight years of genetic analysis in France

(2010) L. Cuisset et al.   ANNALS OF THE RHEUMATIC DISEASES

Autoinflammatory Diseases: Clinical and Genetic Advances

(2010) S. Farasat et al.   ARCHIVES OF DERMATOLOGY

Use of Canakinumab in the Cryopyrin-Associated Periodic Syndrome

(2009) Helen J. Lachmann et al.   NEW ENGLAND JOURNAL OF MEDICINE

A pilot study to evaluate the safety and efficacy of the long-acting interleukin-1 inhibitor rilonacept (interleukin-1 trap) in patients with familial cold autoinflammatory syndrome

(2008) Raphaela Goldbach-Mansky et al.   ARTHRITIS AND RHEUMATISM

Efficacy and safety of rilonacept (interleukin-1 trap) in patients with cryopyrin-associated periodic syndromes: Results from two sequential placebo-controlled studies

(2008) Hal M. Hoffman et al.   ARTHRITIS AND RHEUMATISM

Autoinflammatory diseases

(2008) Isabelle Touitou et al.   BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY

Familial cold auto-inflammatory syndrome (FCAS): characterization of symptomatology and impact on patients' lives

(2008) Beate Stych et al.   CURRENT MEDICAL RESEARCH AND OPINION

NLR, the nucleotide-binding domain leucine-rich repeat containing gene family

(2008) Zhengmao Ye et al.   CURRENT OPINION IN IMMUNOLOGY